Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Universite Paris Descartes patents


Recent patent applications related to Universite Paris Descartes. Universite Paris Descartes is listed as an Agent/Assignee. Note: Universite Paris Descartes may have other listings under different names/spellings. We're not affiliated with Universite Paris Descartes, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite Paris Descartes-related inventors


Methods and pharmaceutical compositions (ntsr1 inhibitors) for the treatment of hepatocellular carcinomas

The present disclosure relates to methods and pharmaceutical compositions for the treatment of hepatocellular carcinomas (hcc in abbreviation, the term “hepatocellular carcinoma” has its general meaning in the art and refers to the cancer developed in hepatocytes see page 2 lines 24-30 of the present application) comprising administering to the subject a therapeutically effective amount of an inhibitor of ntsr1 (neurotensin receptor 1) activation or expression. The examples show the expression of ntsr1 in hcc cell lines and the role of the nts/ntsr1 complex in these cell lines, thereby showing the role of the complex in tumour progression.. ... Universite Paris Descartes

Vaccines for preventing meningococcal infections

The present invention stems from the finding that the interaction between the β2 adrenoceptor (β2ap) and type iv pilus-associated proteins initiates a process leading to the opening of the blood brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type iv pilus-associated proteins and the β2ap.. ... Universite Paris Descartes

Treatment of a disease associated with retinal degenerative disorder

Treatment of a disease associated with retinal degenerative disorder. The present invention relates to human transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder.. ... Universite Paris Descartes

Methods for the prevention and the treatment of extracapillary glomerulonephritis

The present invention relates to the prevention and the treatment of extracapillary glomerulonephritis such as rapidly progressive glomerulonephritis and collapsing glomerulonephritis.. . ... Universite Paris Descartes

Anti-neurotensin long fragment antibodies and uses thereof

The present invention relates to a neutralising antibody which is capable of binding to neurotensin with high affinity. The antibody of the present invention neutralises the activity of neurotensin, in particular the oncogenic activities of neurotensin. ... Universite Paris Descartes

Methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis

The present invention relates to methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis. In particular, the present invention relates to an inhibitor of neutrophil gelatinase-associated lipocalin (ngal) activity or expression for use in a method for treating or preventing cardiovascular fibrosis in a subject in need thereof.. ... Universite Paris Descartes

Methods for the diagnostic of an autoimmune disease

An in vitro method for determining whether a patient has, or is at risk of having or developing an autoimmune disease or for assessing the severity or predicting the outcome of an autoimmune disease, comprising a step of detecting or quantifying in a biological sample obtained from said patient an immune anti-il2 response, peptides specifically recognised by anti-il2 antibodies or il-2-specific t cells of t1d, systemic lupus erythematosus, rheumatoid arthritis, sjögren's syndrome and autoimmune polymyositis patients, and pharmaceutical compositions.. . ... Universite Paris Descartes

Compositions having means for targeting at least one antigen to dendritic cells

A composition that can be used as a vaccine containing means for targeting at least one antigen to dendritic cells and as adjuvants a granulocyte macrophage colony stimulating factor and a cpg oligodeoxynucleotide and/or a cpg-like oligodeoxynucleotide. This composition can used to treat cancers, infectious diseases caused by bacterial, viral, fungal, parasitic or protozoan infections, allergies and/or autoimmune diseases.. ... Universite Paris Descartes








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite Paris Descartes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite Paris Descartes with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###